Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

RKS-Fzd7 subtype NGS Wnt Citations (2)

Originally described in: Next-Generation Surrogate Wnts Support Organoid Growth and Deconvolute Frizzled Pleiotropy In Vivo.
Miao Y, Ha A, de Lau W, Yuki K, Santos AJM, You C, Geurts MH, Puschhof J, Pleguezuelos-Manzano C, Peng WC, Senlice R, Piani C, Buikema JW, Gbenedio OM, Vallon M, Yuan J, de Haan S, Hemrika W, Rosch K, Dang LT, Baker D, Ott M, Depeille P, Wu SM, Drost J, Nusse R, Roose JP, Piehler J, Boj SF, Janda CY, Clevers H, Kuo CJ, Garcia KC Cell Stem Cell. 2020 Aug 14. pii: S1934-5909(20)30358-1. doi: 10.1016/j.stem.2020.07.020.
PubMed Journal

Articles Citing RKS-Fzd7 subtype NGS Wnt

Articles
Generation of the tumor-suppressive secretome from tumor cells. Liu S, Sun X, Li K, Zha R, Feng Y, Sano T, Dong C, Liu Y, Aryal UK, Sudo A, Li BY, Yokota H. Theranostics. 2021 Jul 25;11(17):8517-8534. doi: 10.7150/thno.61006. eCollection 2021. PubMed
Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells. Li KX, Sun X, Li BY, Yokota H. Cancers (Basel). 2021 Nov 9;13(22). pii: cancers13225593. doi: 10.3390/cancers13225593. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.